Literature DB >> 28161258

Pathology of Chronic Total Occlusion in Bare-Metal Versus Drug-Eluting Stents: Implications for Revascularization.

Hiroyoshi Mori1, Christoph Lutter1, Kazuyuki Yahagi1, Emanuel Harari1, Robert Kutys1, David R Fowler2, Elena Ladich1, Michael Joner1, Renu Virmani1, Aloke V Finn3.   

Abstract

OBJECTIVES: The aim of this study was to explore the pathology of in-stent chronic total occlusion (IS-CTO) in bare-metal (BMS) versus drug-eluting stents (DES).
BACKGROUND: Despite a relatively high prevalence of IS-CTO, little is known about the underlying etiology and histopathologic characteristics of the occlusion.
METHODS: From CVPath Institute's stent registry of human native coronary arteries, the authors identified 56 lesions (32 BMS and 24 DES) from 54 patients with IS-CTO. Sections of stented coronary arteries were examined for histological features of IS-CTO. The underlying mechanisms of IS-CTO were determined along with the histopathological characteristics.
RESULTS: The pathological prevalence of IS-CTO was significantly higher in BMS versus DES cases at autopsy (11.7% vs. 5.9%; p = 0.01). The most frequent etiology of IS-CTO was acute thrombotic occlusion (51% in BMS vs. 67% in DES), followed by restenosis (31% vs. 8%) and neoatherosclerotic rupture (9% vs. 4%). The proximal lumen pattern was abrupt in 67% of BMS and in 57% of DES, whereas the distal lumen was tapered in 68% of BMS and in 74% of DES. BMS showed longer fibrous cap of IS-CTO than DES in both proximal (4.6 mm vs. 1.6 mm; p = 0.06) and distal (5.3 mm vs. 2.0 mm; p = 0.06).
CONCLUSIONS: At autopsy, IS-CTO was observed more frequently in BMS versus DES, with acute thrombotic occlusion being the most frequent cause, followed by restenosis (especially in BMS) and neoatherosclerotic rupture. Our findings shed new light upon the frequency, mechanisms, and pathology of IS-CTO. Copyright Â
© 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic total occlusion; in-stent chronic total occlusion; neoatherosclerosis; restenosis; stent thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28161258     DOI: 10.1016/j.jcin.2016.11.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  7 in total

1.  Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry.

Authors:  Gabriel T R Pereira; Alessio La Manna; Yasuhiro Ichibori; Armando Vergara-Martel; Bruno Ramos Nascimento; Abdul Jawwad Samdani; Davide Capodanno; Guido D'Agosta; Giacomo Gravina; Giuseppe Venuti; Corrado Tamburino; Guilherme F Attizzani
Journal:  Int J Cardiovasc Imaging       Date:  2019-06-07       Impact factor: 2.357

2.  Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.

Authors:  Yuchao Zhang; Zheng Wu; Shaoping Wang; Tong Liu; Jinghua Liu
Journal:  Cardiovasc Drugs Ther       Date:  2022-08-05       Impact factor: 3.947

3.  Stenting-induced Vasa Vasorum compression and subsequent flow resistance: a finite element study.

Authors:  Andrea Corti; Annalisa De Paolis; John Tarbell; Luis Cardoso
Journal:  Biomech Model Mechanobiol       Date:  2020-08-04

4.  Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.

Authors:  Hideki Miyachi; James W Reinhardt; Satoru Otsuru; Shuhei Tara; Hidetaka Nakayama; Tai Yi; Yong-Ung Lee; Shinka Miyamoto; Toshihiro Shoji; Tadahisa Sugiura; Christopher K Breuer; Toshiharu Shinoka
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

5.  Very Late Pathological Responses to Cobalt-Chromium Everolimus-Eluting, Stainless Steel Sirolimus-Eluting, and Cobalt-Chromium Bare Metal Stents in Humans.

Authors:  Hiroyoshi Mori; Dheeraj R Atmakuri; Sho Torii; Ryan Braumann; Samantha Smith; Hiroyuki Jinnouchi; Anuj Gupta; Emanuel Harari; Melsi Shkullaku; Robert Kutys; David Fowler; Maria Romero; Renu Virmani; Aloke V Finn
Journal:  J Am Heart Assoc       Date:  2017-11-17       Impact factor: 5.501

6.  Effects of Altered Levels of Pro- and Anti-Inflammatory Mediators on Locations of In-Stent Reocclusions in Elderly Patients.

Authors:  Xia Li; Dianxuan Guo; Ying Chen; Youdong Hu; Fenglin Zhang
Journal:  Mediators Inflamm       Date:  2020-09-23       Impact factor: 4.711

7.  A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.

Authors:  Min-Tao Gai; Bing Zhu; Xiao-Cui Chen; Fen Liu; Xiang Xie; Xiao-Ming Gao; Xiang Ma; Zhen-Yan Fu; Yi-Tong Ma; Bang-Dang Chen
Journal:  Lipids Health Dis       Date:  2021-09-29       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.